Center Care (Meritain) policies, page 96

Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Center Care (Meritain), by title.

Center Care (Meritain) policies
PolicyDetailsCodesSource
Continuous Passive Motion (CPM) Machines0010 · Commercial44Original policy ↗
Corneal Graft and Amniotic Membrane Transplantation, Corneal Stromal Lenticule Transplantation, Limbal Stem Cell Transplantation, or Sural Nerve Grafting for Ocular Indications0293 · Commercial12Original policy ↗
Corneal Remodeling0023 · Commercial45Original policy ↗
Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions0491 · Commercial13Original policy ↗
Corticosteroid Pulmicort 1mg Post Limit PA Policy 2495-J UDR 10-20232495-J · Commercial—Original policy ↗
Corticosteroids Topical (Brand Only) PA with Limit Policy 2435-C UDR 04-20232435-C · Commercial—Original policy ↗
Cosmetic Surgery and Procedures0031 · Commercial149Original policy ↗
Cranial Remodeling0379 · Commercial21Original policy ↗
Cryoablation0100 · Commercial37Original policy ↗
Cystagon SGM 2089-A P20252089-A · Commercial—Original policy ↗
Daybue 5833-A SGM P20245833-A · Commercial—Original policy ↗
Deep Sedation/General Anesthesia and IV Sedation for Oral and Maxillofacial Surgery and Dental Services (016)016 · Effective Mar 13, 2026 · Commercial11Original policy ↗
deferasirox-Exjade-Jadenu SGM 1622-A P20251622-A · Commercial—Original policy ↗
deferoxamine-Desferal SGM 1620-A P20251620-A · Commercial—Original policy ↗
Dendritic Cell Immunotherapy0377 · Commercial—Original policy ↗
Denileukin Diftitox-cxdl (Lymphir)1070 · Commercial5Original policy ↗
Dental radiographic examinations policy (048)048 · Effective Mar 13, 2026 · Commercial58Original policy ↗
Dental Services, Oral and Maxillofacial Surgery: Coverage under Medical Plans (020)020 · Effective Mar 13, 2026 · Commercial—Original policy ↗
Desmopressin Nasal and Oral PA Policy 61-A 01-202361-A · Commercial—Original policy ↗
Desvenlafaxine, Fetzima ST with Limit, Post PA Policy 1888-E 03-20221888-E · Commercial—Original policy ↗
Diabetic Test Strips Limit 1372-H P04-20261372-H · Commercial—Original policy ↗
Diabetic Test Strips Post Limit PA 1373-J P04-20261373-J · Commercial—Original policy ↗
Diagnosis of Vaginitis0643 · Commercial37Original policy ↗
Dialysis0541 · Commercial114Original policy ↗
Dibenzyline ST with Limit, Post PA (Aetna FI ACF, Aetna FI ACFC Only) 3080-E P07-20253080-E · Commercial—Original policy ↗
Diphtheria, Tetanus, and Pertussis Vaccines0653 · Commercial9Original policy ↗
Distraction Osteogenesis for Craniofacial Defects0549 · Commercial25Original policy ↗
Ditropan XL ST with Limit, Post PA (Aetna FI ACF, Aetna FI ACFC Only) Policy 2962-E UDR 05-20232962-E · Commercial—Original policy ↗
Donanemab-azbt (Kisunla)1066 · Commercial21Original policy ↗
Donor Lymphocyte Infusion0638 · Commercial17Original policy ↗
Dronabinol Limit 137-H P01-2026137-H P01-2026 · Commercial—Original policy ↗
Dronabinol PA with Limit 392-C P01-2026392-C · Commercial—Original policy ↗
Dronabinol Post Limit PA Policy 138-J UDR 01-2024a138-J · Commercial—Original policy ↗
Drug-Eluting Stents0621 · Commercial31Original policy ↗
Dry Eye Disease Agents PA with Limit 1955-C P11-20251955-C · Commercial—Original policy ↗
Dry Eyes0457 · Commercial36Original policy ↗
Dysport 2248-A SGM P20222248-A · Commercial—Original policy ↗
Early Intervention Programs0444 · Commercial29Original policy ↗
Eating Disorders0511 · Commercial111Original policy ↗
Econazole Limit, Post PA Policy 2956-HJ UDR 08-20232956-HJ · Commercial—Original policy ↗
Electrical Bioimpedance for Cardiac Output Monitoring and Other Selected Indications0472 · Commercial3Original policy ↗
Electrical Stimulation for Xerostomia (022)022 · Effective Mar 13, 2026 · Commercial—Original policy ↗
Electrocochleogram and Perilymphatic Pressure Measurement0564 · Commercial10Original policy ↗
Electroconvulsive Therapy0445 · Commercial20Original policy ↗
Electrodiagnostic Testing0502 · Commercial36Original policy ↗
Electromagnetic Navigation-Guided Bronchoscopy0776 · Commercial26Original policy ↗
Electrothermal Arthroscopy0545 · Commercial16Original policy ↗
Eligard-Vabrinty SGM 1966-A, 6043-A P20261966-A, 6043-A P2026 · Commercial—Original policy ↗
Elmiron Limit, Post PA 2961-HJ P05-20252961-HJ · Commercial—Original policy ↗
Elmiron Limit, Post PA Policy 2961-HJ 05-20222961-HJ · Commercial—Original policy ↗

Back to Center Care (Meritain)

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.